Skip to content

A clinical trial to study the effect of two drugs Sarshap Upanah & Mgso4 Glycerine in abscess

A standard controlled clinical trial of Sarshap Upanah Brassica Nigra in management of vranashopha before pakwastha

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017760
Enrollment
60
Registered
2019-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L029- Cutaneous abscess, furuncle and carbuncle, unspecified

Interventions

Intervention1: Sarshap Upanah for local application: Group A 30 people having vranashopha will be administered with Sarshap Upanah for local application for10 days Control Intervention1: MgSo4 and Gly

Sponsors

PDEAS College of Ayurveda and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having the signs and symptoms of vranashopha before pakwastha All night as well as Aagantuja condition in acute and chronic stage

Exclusion criteria

Exclusion criteria: Vranashopha with pakwastha, patient with HIV,k/c/o DM,septicemia

Design outcomes

Primary

MeasureTime frame
To study the effect of Sarshap Upanah To study the effect of MgSo4 and GlycerineTimepoint: Daily follow up upto 5 days then 7th day and 10 the day

Secondary

MeasureTime frame
To study the adverse effects if any To observe the efficasy of Sarshap Upanah To observe the efficasy of MgSo4 and GlycerineTimepoint: Daily follow up upto 5 days then 7 th day and 10 th day

Countries

India

Contacts

Public ContactDrBhalchandra Deshpande

PDEAS College of Ayurveda and research centre

drbndeshpande@gmail.com9970108596

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026